Thursday, June 28, 2018

Old drug provides promising new avenue for treatment of MND

›
In continuation of my update on  ebselen An international study led by biochemists at the University of Liverpool has shown that the d...
Wednesday, June 27, 2018

FDA approves non-opioid treatment for opioid withdrawal

›
Lucemyra, an oral selective alpha 2-adrenergic receptor agonist, limits the body's output of norepinephrine, the hormone believed to p...
Tuesday, June 26, 2018

Sustained use of oxymetazoline cream efficacious for rosacea

›
In continuation of my update on  oxymetazoline Zoe Diana Draelos, M.D., from Dermatology Consulting Services in High Point, Tenn...
Saturday, June 23, 2018

New diabetes drug may help people with obesity lose weight

›
In continuation of my update on  semaglutide A compound that mimics a naturally occurring hormone that regulates appetite ma...
Friday, June 22, 2018

Drug used to treat daytime sleepiness does not appear to improve driving in those with sleep apnea

›
  Armodafinil   In "Does Armodafinil Improve Driving Task Performance and Weight Loss in Sleep Apnea? A Randomized Trial,"...
Thursday, June 21, 2018

Novartis Drug Tasigna Approved by FDA to Treat Children with Rare Form of Leukemia

›
In continuation of my update on Nilotinib Novartis announced today that the US Food and Drug Administration (FDA) expanded t...
Wednesday, June 20, 2018

Oral drug reduces venous thromboembolism recurrence among cancer patients

›
In continuation of my update on   rivaroxaban Research from the University of Warwick indicates that taking a tablet a day can help trea...
Tuesday, June 19, 2018

Osteoporosis drug may be cardioprotective in hip fracture patients

›
In continuation of my update on alendronate The osteoporosis drug alendronate was linked with a reduced risk of cardiovascular death, he...
Saturday, June 16, 2018

New drug reduces symptoms of Rett syndrome in preclinical models

›
A new article published in the  Cell Reports  describes how a new drug is able to reduce the symptoms and activate the dormant neurons cha...
Wednesday, June 13, 2018

FDA Approves Supplemental New Drug Application for Myrbetriq (mirabegron) for Use in Combination with Solifenacin Succinate for the Treatment of Overactive Bladder Symptoms

›
In continuation of my update on  mirabegron Astellas Pharma Inc. announced  that the U.S. Food and Drug Administration (FDA) has app...
Tuesday, June 12, 2018

Mepivacaine is found to be an effective spinal anesthetic for knee replacement surgery

›
A numbing medicine largely abandoned decades ago for pain control during surgery could be making a comeback as an effective spinal anesthe...
Saturday, June 9, 2018

FDA Approves Tafinlar + Mekinist for the Treatment of BRAF-Positive Anaplastic Thyroid Cancer

›
In continuation of my update on  Tafinlar  ( dabrafenib ) and  Mekinist  ( trametinib ) The U.S. Food and Drug Administration approved...
Friday, June 8, 2018

Methylene blue could hold the key to future anti-aging treatment

›
In continuation of my update on Methylene Blue In a  keynote address to the 19 th  World Dermatology Congress, renowned dermatologist Dr...
Thursday, June 7, 2018

Phase 2 study of dexpramipexole in hypereosinophilic syndromes meets its co-primary endpoints

›
Knopp Biosciences LLC today announced the publication of a report in the journal  Blood that a Phase 2 study of dexpramipexole in hypereos...
Wednesday, June 6, 2018

Study identifies molecule that may be critical to repair of white matter

›
In continuation of my update on  hyaluronic acid (HA) A new study identifies a molecule that may be critical to the repair of whit...